Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8777598 | 0.90 | ALDH1A1 (0.43) | L3MBTL1ALDH1A1KDM4ENPC1RAB9A | |
| SCHEMBL8777613 | 0.84 | MAPK1 (0.43) | L3MBTL1ALDH1A1NPC1SMN1; SMN2 | |
| SCHEMBL8777439 | 0.83 | L3MBTL1 (0.47) | L3MBTL1ALDH1A1KDM4ENPC1RAB9A | |
| SCHEMBL8777505 | 0.83 | LMNA (0.46) | L3MBTL1ALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL8776686 | 0.83 | MAOA (0.40) | L3MBTL1PKMALDH1A1KDM4ENPC1 | |
| SCHEMBL8776454 | 0.83 | MAOA (0.42) | L3MBTL1PKMALDH1A1KDM4ENPC1 | |
| SCHEMBL8777685 | 0.82 | MAPT (0.42) | L3MBTL1ALDH1A1KDM4E | |
| SCHEMBL8777721 | 0.79 | ALDH1A1 (0.48) | L3MBTL1ALDH1A1KDM4ENPC1RAB9A | |
| SCHEMBL8777628 | 0.79 | CYP1A2 (0.41) | L3MBTL1ALDH1A1KDM4E | |
| SCHEMBL8777719 | 0.79 | LMNA (0.47) | L3MBTL1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012069652-A2 | FUNGICIDE MIXTURES | SYNGENTA PARTICIPATIONS AG (CH) | 2012-05-31 | — | — | WO | disclosed |
| US-20120129875-A1 | SUBSTITUTED QUINAZOLINES AS FUNGICIDES | SYNGENTA CROP PROTECTION, LLC (US) | 2012-05-24 | — | — | US | disclosed |
| US-20120129875-A1 | SUBSTITUTED QUINAZOLINES AS FUNGICIDES | SYNGENTA CROP PROTECTION, LLC (US) | 2012-05-24 | — | — | US | disclosed |
| WO-2010136475-A1 | SUBSTITUTED QUINAZOLINES AS FUNGICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2010-12-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120129875-A1 | SUBSTITUTED QUINAZOLINES AS FUNGICIDES | NAT1, NQO2, NOX1 | L3MBTL1 3069/4885PKM 3353/4885ALDH1A1 1125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.